Our advisory work starts from a position of respect
for our clients' organization, people,
products and science.
We have devoted our careers to the life
sciences industry and have the deepest respect
and admiration for the participants in it.
OUR TRACK RECORD
We are a very active advisor in the market.
Torreya Partners has successfully closed over
100 assignments since our founding in 2007.
We often take an operating perspective
to strategic and transaction work.
Partial Royalty Monetization
August 9-10, 2017
Canaccord Genuity Conf
August 23-25, 2017
August 26-30, 2017
December 21, 2016
XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from Two License Agreements to HealthCare Royalty Partners and Provides Corporate Update
December 15, 2016
Opiant Pharmaceuticals, Inc. Announces NARCAN® Nasal Spray Royalty Monetization
October 25, 2015
Everstone Capital Invests Rs 222 crore in Rubicon Research